2024 Q3 Form 10-Q Financial Statement

#000190359624000535 Filed on August 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $1.760M $1.490M $1.566M
YoY Change 29.99% -4.84% 37.6%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.656M $1.394M
YoY Change 18.74% 46.45%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $33.23K $22.59K $139.6K
YoY Change 60.59% -83.82% 3.99%
% of Gross Profit
Operating Expenses $2.484M $1.768M $1.534M
YoY Change 88.11% 15.24% 41.2%
Operating Profit -$723.7K -$277.5K $32.15K
YoY Change -2258.52% -963.28% -37.9%
Interest Expense -$187.8K -$319.3K
YoY Change -41.2% 53.72%
% of Operating Profit -993.28%
Other Income/Expense, Net $339.00
YoY Change -67.56%
Pretax Income -$1.001M -$465.3K -$451.5K
YoY Change -147.84% 3.05% 191.45%
Income Tax -$219.4K
% Of Pretax Income
Net Earnings -$363.4K -$232.2K
YoY Change 56.55% 19.8%
Net Earnings / Revenue -24.39% -14.83%
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 7.729B shares 3.729B shares 3.729B shares
Diluted Shares Outstanding 7.207B shares 3.729B shares 3.729B shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $31.10K $27.81K
YoY Change 11.83% -59.78%
Cash & Equivalents $60.86K $31.10K $27.81K
Short-Term Investments
Other Short-Term Assets $1.478K $1.478K $55.30K
YoY Change -97.64% -97.33% 193.84%
Inventory
Prepaid Expenses $28.78K $26.45K $26.00K
Receivables $381.3K $272.9K $470.8K
Other Receivables $13.57K $0.00
Total Short-Term Assets $472.4K $345.5K $579.9K
YoY Change -40.54% -40.43% 22.1%
LONG-TERM ASSETS
Property, Plant & Equipment $756.4K $763.0K $531.3K
YoY Change 44.43% 43.61% -82.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $472.4K $400.0K
YoY Change 18.1% 7852.29%
Total Long-Term Assets $11.84M $12.00M $3.256M
YoY Change 5.62% 268.71% -46.26%
TOTAL ASSETS
Total Short-Term Assets $472.4K $345.5K $579.9K
Total Long-Term Assets $11.84M $12.00M $3.256M
Total Assets $12.32M $12.35M $3.836M
YoY Change 2.57% 221.97% -41.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $507.9K $131.2K
YoY Change 287.0% -65.54%
Accrued Expenses $275.5K $311.3K
YoY Change -11.5% 17.99%
Deferred Revenue
YoY Change
Short-Term Debt $2.466M $2.379M $793.7K
YoY Change 1874.62% 199.81% 145.32%
Long-Term Debt Due $2.461M $23.08K
YoY Change 10562.26% -99.41%
Total Short-Term Liabilities $7.541M $8.546M $9.857M
YoY Change -2.23% -13.3% -29.71%
LONG-TERM LIABILITIES
Long-Term Debt $1.952M $637.2K
YoY Change 206.44% -3.25%
Other Long-Term Liabilities $9.991M $1.042M
YoY Change 859.05% -23.01%
Total Long-Term Liabilities $11.91M $11.94M $1.865M
YoY Change 21.5% 540.3% -16.99%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.541M $8.546M $9.857M
Total Long-Term Liabilities $11.91M $11.94M $1.865M
Total Liabilities $19.45M $20.49M $11.72M
YoY Change 11.05% 74.79% -27.96%
SHAREHOLDERS EQUITY
Retained Earnings -$44.09M -$43.19M -$44.04M
YoY Change 5.08% -1.91% -1.09%
Common Stock $77.29M $37.29M $37.29M
YoY Change 107.27% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$7.134M -$8.140M -$7.887M
YoY Change
Total Liabilities & Shareholders Equity $12.32M $12.35M $3.836M
YoY Change 2.57% 221.97% -41.29%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income -$363.4K -$232.2K
YoY Change 56.55% 19.8%
Depreciation, Depletion And Amortization $33.23K $22.59K $139.6K
YoY Change 60.59% -83.82% 3.99%
Cash From Operating Activities -$163.9K -$70.38K
YoY Change 132.95% -122.27%
INVESTING ACTIVITIES
Capital Expenditures $26.42K -$30.78K
YoY Change -185.83% -78.15%
Acquisitions
YoY Change
Other Investing Activities -$928.4K
YoY Change
Cash From Investing Activities -$954.8K $80.78K
YoY Change -1281.99% -157.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.017M -92.52K
YoY Change -1199.02% -215.06%
NET CHANGE
Cash From Operating Activities -163.9K -70.38K
Cash From Investing Activities -954.8K 80.78K
Cash From Financing Activities 1.017M -92.52K
Net Change In Cash -102.0K -82.12K
YoY Change 24.15% -132.13%
FREE CASH FLOW
Cash From Operating Activities -$163.9K -$70.38K
Capital Expenditures $26.42K -$30.78K
Free Cash Flow -$190.4K -$39.60K
YoY Change 380.73% -108.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Security12b Title
Security12bTitle
Common shares 
dei Trading Symbol
TradingSymbol
GRST
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7729053805 shares
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31102 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
68573 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
272872 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
313338 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
26453 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3030 usd
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
usd
CY2023Q4 us-gaap Long Term Commercial Paper Current
LongTermCommercialPaperCurrent
usd
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
usd
CY2023Q4 us-gaap Commercial Paper Noncurrent
CommercialPaperNoncurrent
usd
CY2024Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
usd
CY2024Q2 us-gaap Management Fee Expense
ManagementFeeExpense
usd
us-gaap Management Fee Expense
ManagementFeeExpense
usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2024Q2 GRST Penalty On Convertible Debt
PenaltyOnConvertibleDebt
usd
CY2024Q2 us-gaap Loan Processing Fee
LoanProcessingFee
usd
CY2023Q2 us-gaap Interest Income Other
InterestIncomeOther
usd
us-gaap Interest Income Other
InterestIncomeOther
usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
usd
CY2024Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
usd
CY2024Q2 us-gaap Deferred Policy Acquisition Cost Foreign Currency Translation Adjustment And Other
DeferredPolicyAcquisitionCostForeignCurrencyTranslationAdjustmentAndOther
usd
us-gaap Deferred Policy Acquisition Cost Foreign Currency Translation Adjustment And Other
DeferredPolicyAcquisitionCostForeignCurrencyTranslationAdjustmentAndOther
usd
GRST Penalty On Convertible Promissory Notes
PenaltyOnConvertiblePromissoryNotes
usd
GRST Deferred Tax Movement
DeferredTaxMovement
usd
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
usd
GRST Acquisition Of Business
AcquisitionOfBusiness
usd
GRST Acquisition Of Minority Shareholder Interest
AcquisitionOfMinorityShareholderInterest
usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
usd
us-gaap Repayments Of First Mortgage Bond
RepaymentsOfFirstMortgageBond
usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
usd
us-gaap Proceeds From Subordinated Short Term Debt
ProceedsFromSubordinatedShortTermDebt
usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
GRST Promissory Note Issue On Acquisition Of Minority Shareholders Interest
PromissoryNoteIssueOnAcquisitionOfMinorityShareholdersInterest
usd
GRST Disposal Of Subsidiary To Related Parties
DisposalOfSubsidiaryToRelatedParties
usd
GRST Deemed Extinguishment Of Debt By Related Parties
DeemedExtinguishmentOfDebtByRelatedParties
usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
usd
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2023 GRST Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodExercisePrice
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
GRST Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
GRST Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodExercisePrice
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
GRST Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodExercisePrice
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
18159 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1478 usd
CY2024Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
13571 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
345476 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
403100 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
762979 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
508401 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
715961 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
894952 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10052463 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9323723 usd
CY2024Q2 us-gaap Deposit Contracts Assets
DepositContractsAssets
472393 usd
CY2023Q4 us-gaap Deposit Contracts Assets
DepositContractsAssets
389000 usd
CY2024Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
12003796 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
11116076 usd
CY2024Q2 us-gaap Assets
Assets
12349272 usd
CY2023Q4 us-gaap Assets
Assets
11519176 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
507899 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
352101 usd
CY2024Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
2169570 usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
4419927 usd
CY2024Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
2379445 usd
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
680672 usd
CY2024Q2 us-gaap Long Term Commercial Paper Current
LongTermCommercialPaperCurrent
267500 usd
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
284064 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
211961 usd
CY2024Q2 us-gaap Government Assistance Liability Current
GovernmentAssistanceLiabilityCurrent
15062 usd
CY2023Q4 us-gaap Government Assistance Liability Current
GovernmentAssistanceLiabilityCurrent
14962 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
275457 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
38563 usd
CY2024Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
8714 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
8426 usd
CY2024Q2 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
2638078 usd
CY2023Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
2572292 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
8545789 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8298904 usd
CY2024Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
1730048 usd
CY2024Q2 us-gaap Government Assistance Liability Noncurrent
GovernmentAssistanceLiabilityNoncurrent
12920 usd
CY2024Q2 us-gaap Commercial Paper Noncurrent
CommercialPaperNoncurrent
197500 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9990756 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9383557 usd
CY2024Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
12017 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
16475 usd
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
11943241 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
9420552 usd
CY2024Q2 us-gaap Liabilities
Liabilities
20489030 usd
CY2023Q4 us-gaap Liabilities
Liabilities
17719456 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4000000 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
40000 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
40000 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3729053805 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3729053805 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
37290539 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
37290539 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25087925 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
26187925 usd
CY2024Q2 GRST Discount For Shares Issued Below Par Value
DiscountForSharesIssuedBelowParValue
-27363367 usd
CY2023Q4 GRST Discount For Shares Issued Below Par Value
DiscountForSharesIssuedBelowParValue
-27363367 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43194855 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-42355377 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-8139758 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-6200280 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12349272 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11519176 usd
CY2024Q2 us-gaap Revenues
Revenues
1490100 usd
CY2023Q2 us-gaap Revenues
Revenues
1565959 usd
us-gaap Revenues
Revenues
2790200 usd
us-gaap Revenues
Revenues
2866005 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
363230 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
265165 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
637775 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
506402 usd
CY2024Q2 GRST Payments For Rents
PaymentsForRents
274130 usd
CY2023Q2 GRST Payments For Rents
PaymentsForRents
105933 usd
GRST Payments For Rents
PaymentsForRents
539263 usd
GRST Payments For Rents
PaymentsForRents
220497 usd
CY2023Q2 us-gaap Management Fee Expense
ManagementFeeExpense
215503 usd
us-gaap Management Fee Expense
ManagementFeeExpense
243003 usd
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
301132 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
177910 usd
us-gaap Professional Fees
ProfessionalFees
455682 usd
us-gaap Professional Fees
ProfessionalFees
289114 usd
CY2024Q2 us-gaap Salaries And Wages
SalariesAndWages
717032 usd
CY2023Q2 us-gaap Salaries And Wages
SalariesAndWages
629707 usd
us-gaap Salaries And Wages
SalariesAndWages
1440773 usd
us-gaap Salaries And Wages
SalariesAndWages
1221743 usd
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
112086 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
139595 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
223292 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
278074 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
1767610 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1533813 usd
us-gaap Operating Expenses
OperatingExpenses
3296785 usd
us-gaap Operating Expenses
OperatingExpenses
2758833 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-277510 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
32146 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-506585 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
107172 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
339 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
339 usd
CY2023Q2 GRST Penalty On Convertible Debt
PenaltyOnConvertibleDebt
34688 usd
GRST Penalty On Convertible Debt
PenaltyOnConvertibleDebt
34688 usd
CY2023Q2 us-gaap Loan Processing Fee
LoanProcessingFee
130000 usd
us-gaap Loan Processing Fee
LoanProcessingFee
130000 usd
CY2024Q2 us-gaap Interest Income Other
InterestIncomeOther
523 usd
us-gaap Interest Income Other
InterestIncomeOther
1098 usd
CY2024Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
106914 usd
CY2023Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
143981 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
200100 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
301077 usd
CY2024Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
75240 usd
CY2023Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
87526 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
138402 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
164447 usd
CY2024Q2 GRST Foreign Exchange Movements
ForeignExchangeMovements
6134 usd
CY2023Q2 GRST Foreign Exchange Movements
ForeignExchangeMovements
87791 usd
GRST Foreign Exchange Movements
ForeignExchangeMovements
-4511 usd
GRST Foreign Exchange Movements
ForeignExchangeMovements
90746 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-465275 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-451501 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-839478 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-613447 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-219346 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-205575 usd
CY2024Q2 us-gaap Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
-465275 usd
CY2023Q2 us-gaap Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
-232155 usd
us-gaap Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
-839478 usd
us-gaap Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
-407872 usd
CY2024Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-101842 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
93880 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-101842 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
96848 usd
CY2024Q2 GRST Net Income Loss Stockholders
NetIncomeLossStockholders
-363433 usd
CY2023Q2 GRST Net Income Loss Stockholders
NetIncomeLossStockholders
-326035 usd
GRST Net Income Loss Stockholders
NetIncomeLossStockholders
-737636 usd
GRST Net Income Loss Stockholders
NetIncomeLossStockholders
-504720 usd
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
5984 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
11901 usd
CY2023Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
17822 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
35324 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-363433 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-349841 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-737636 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-551945 usd
CY2023Q2 us-gaap Deferred Policy Acquisition Cost Foreign Currency Translation Adjustment And Other
DeferredPolicyAcquisitionCostForeignCurrencyTranslationAdjustmentAndOther
-6569 usd
us-gaap Deferred Policy Acquisition Cost Foreign Currency Translation Adjustment And Other
DeferredPolicyAcquisitionCostForeignCurrencyTranslationAdjustmentAndOther
-5065 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-363433 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-343272 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-737636 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-546880 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3729053805 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3729053805 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3729053805 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3729053805 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3729053805 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3729053805 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3729053085 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3729053085 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-6200280 usd
CY2024Q1 GRST Net Incomes Loss
NetIncomesLoss
-374203 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-6574483 usd
CY2024Q2 GRST Acquisition Of Minority Shareholders Interest
AcquisitionOfMinorityShareholdersInterest
-1100000 usd
CY2024Q2 GRST Net Incomes Loss
NetIncomesLoss
-465275 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-8139758 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-9232543 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
-1504 usd
CY2023Q1 GRST Dividends Accrued
DividendsAccrued
-23419 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-9433183 usd
CY2023Q2 GRST Disposal Of Subsidiary To Related Party
DisposalOfSubsidiaryToRelatedParty
1334885 usd
CY2023Q2 GRST Deemed Extinguishment Of Debt By Related Party
DeemedExtinguishmentOfDebtByRelatedParty
461184 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
6569 usd
CY2023Q2 GRST Net Incomes Loss
NetIncomesLoss
232155 usd
CY2023Q2 GRST Dividends Accrued
DividendsAccrued
-23806 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-7886506 usd
us-gaap Net Income Loss
NetIncomeLoss
-839478 usd
us-gaap Net Income Loss
NetIncomeLoss
-407872 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
223292 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
278074 usd
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
138401 usd
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
164447 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
15517 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
142657 usd
GRST Penalty On Convertible Promissory Notes
PenaltyOnConvertiblePromissoryNotes
34688 usd
GRST Deferred Tax Movement
DeferredTaxMovement
31064 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-171106 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
79460 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6741 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
28034 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-71854 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
339697 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
99837 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-140434 usd
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
-237211 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-269920 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
35488 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
58880 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21642 usd
GRST Acquisition Of Business
AcquisitionOfBusiness
240000 usd
GRST Acquisition Of Minority Shareholder Interest
AcquisitionOfMinorityShareholderInterest
625000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
83393 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1007273 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21642 usd
us-gaap Repayments Of First Mortgage Bond
RepaymentsOfFirstMortgageBond
58320 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
10000 usd
us-gaap Proceeds From Subordinated Short Term Debt
ProceedsFromSubordinatedShortTermDebt
1732000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
570000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
10000 usd
GRST Repayment Of Government Assistance Loans
RepaymentOfGovernmentAssistanceLoans
7493 usd
GRST Repayment Of Government Assistance Loans
RepaymentOfGovernmentAssistanceLoans
7147 usd
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
25970 usd
us-gaap Repayments Of Construction Loans Payable
RepaymentsOfConstructionLoansPayable
4169 usd
us-gaap Repayments Of Construction Loans Payable
RepaymentsOfConstructionLoansPayable
3909 usd
GRST Proceeds From Receivables Funding
ProceedsFromReceivablesFunding
295000 usd
GRST Proceeds From Receivables Funding
ProceedsFromReceivablesFunding
265750 usd
GRST Repayment Of Receivables Funding
RepaymentOfReceivablesFunding
232733 usd
GRST Repayment Of Receivables Funding
RepaymentOfReceivablesFunding
448905 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
52215 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
78246 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1254820 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-210255 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-15098 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
83460 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-37471 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-112949 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
68573 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
140757 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31102 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27808 usd
us-gaap Interest Paid Net
InterestPaidNet
222109 usd
us-gaap Interest Paid Net
InterestPaidNet
90888 usd
GRST Promissory Note Issue On Acquisition Of Minority Shareholders Interest
PromissoryNoteIssueOnAcquisitionOfMinorityShareholdersInterest
475000 usd
GRST Disposal Of Subsidiary To Related Parties
DisposalOfSubsidiaryToRelatedParties
1334885 usd
GRST Deemed Extinguishment Of Debt By Related Parties
DeemedExtinguishmentOfDebtByRelatedParties
461184 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_805_eus-gaap--NatureOfOperations_zTQO9GG2nExh" style="margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>1.   <span id="xdx_821_zb8Lay8sjIN7">Nature of business</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Since 2010, the Company has operated addiction treatment centers. Initially the Company operated an addiction treatment center in Ontario Canada under its Greenestone Muskoka clinic, which was sold on February 14, 2017. Simultaneously with this sale the Company purchased buildings and operated an addiction treatment center in Delray Beach Florida under its Addiction recovery Institute of America subsidiary with a license obtained in December 2016, initially though owned properties in Delray Beach and subsequently though leased properties in West Palm Beach, Florida. Since June 30, 2020, the Company has been actively involved in the management of a treatment center operated by Evernia in West Palm Beach Florida. On July 1, 2021, the Company closed on the acquisition of 75% of ATHI, which owns 100% of Evernia, once the probationary approval of a license was obtained from the Department of Children and Family Services of Florida. Evernia is currently the only active treatment center operated by the Company.</span></p> <p style="margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i>Acquisition of minority shareholders interest in ATHI</i></b></span></p> <p style="margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="background-color: white">On May 15, 2024, the Company entered into a Stock Purchase Agreement whereby it acquired the remaining 25% of ATHI representing 5,000,000 shares from the minority shareholder for gross proceeds of $1,100,000. The Company paid an initial deposit of $25,000 and on closing an additional $600,000. The Company issued a non-interest-bearing promissory note for the remaining balance of $475,000, which promissory note is repayable in installments of $10,000 a month on each monthly anniversary date of the agreement for months one to eight (eight installments) and months ten through seventeen (eight installments), and payments of $157,500 on month nine and month eighteen, for a total of $475,000. </span></p> <p style="margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"></span></p> <p style="margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company sold its real estate on which its Greenstone Muskoka clinic operated during the prior year.</span></p> <p style="margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i>Acquisition of assets and assignment of lease and sub-lease for Boca cove Detox Center</i></b></span></p> <p style="margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On March 22, 2024, the Company executed a LOI to acquire certain assets, including furniture, equipment inventory and supplies of Boca Cove Detox, LLC, along with the assignment of lease and sub-lease for premises located at 899 Meadow Avenue, Boca Raton, Florida. On May 1, 2024 the Company, through its subsidiary Evernia Health Center LLC, entered into a Definitive Agreement whereby the Company would assume the lease for suites 100,101, 201, 202 and 203 located at 899 Meadows Road, Boca Raton, Florida (the “Leased Premises”) and the furniture, fixtures and equipment located therein, upon the assignment of the lease from the property owner. The lease was assigned on June 10, 2024 and the Company entered into a Bill of Sale to give effect to the Definitive Agreement.</span></p> <p style="margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The purchase price was $240,000 which was settled by a deposit of $20,000 and a cash payment of $220,000 and the payment to the Seller of $83,393 for the assumption of the security deposit held by the landlord of the Leased Premises located at 899 Meadows Road</span></p> <p style="margin: 0 0 0 0.25in; text-align: justify; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="background-color: white">            </span></span></p>
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_z1kkrIOSijBi" style="margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>a)   <span id="xdx_86E_zu56KfBdVOqf">Use of Estimates</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The preparation of unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></p> <p style="margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2 us-gaap Fdic Indemnification Asset
FDICIndemnificationAsset
250000 usd
CY2024Q2 us-gaap Other Receivables
OtherReceivables
272872 usd
CY2023Q4 us-gaap Other Receivables
OtherReceivables
313338 usd
CY2024Q2 GRST Working Capital
WorkingCapital
8200000 usd
CY2024Q2 us-gaap Retained Earnings Appropriated
RetainedEarningsAppropriated
-43200000 usd
CY2024Q2 GRST Working Capital
WorkingCapital
8200000 usd
CY2024Q2 us-gaap Liabilities Subject To Compromise
LiabilitiesSubjectToCompromise
8100000 usd
GRST Purchase Price
PurchasePrice
5500000 usd
GRST Fees And Expenses Related To Property Purchase
FeesAndExpensesRelatedToPropertyPurchase
109276 usd
us-gaap Acquisition Costs
AcquisitionCosts
5609276 usd
us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
8500000 usd
GRST Fees And Expenses Related To Disposal Of Property
FeesAndExpensesRelatedToDisposalOfProperty
-406552 usd
us-gaap Gain Loss On Sale Of Unproved Property
GainLossOnSaleOfUnprovedProperty
8093448 usd
us-gaap Gain Loss On Sale Of Property
GainLossOnSaleOfProperty
2484172 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
974028 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
211049 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
762979 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
508401 usd
CY2024Q2 us-gaap Depreciation
Depreciation
22591 usd
CY2023Q2 us-gaap Depreciation
Depreciation
50589 usd
us-gaap Depreciation
Depreciation
44302 usd
us-gaap Depreciation
Depreciation
99084 usd
CY2024Q2 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P5Y
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1789903 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1073942 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
715961 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
894952 usd
CY2024Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
89495 usd
CY2023Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
89495 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
178990 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
178990 usd
CY2024Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
21294 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
26889 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
10052463 usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9323723 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
5595 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
5595 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
771 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1031 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
6366 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
6626 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
374000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
173644 usd
us-gaap Lease Cost
LeaseCost
380366 usd
us-gaap Lease Cost
LeaseCost
180270 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
771 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
1031 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
374000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
173644 usd
GRST Financing Cash Flows From Finance Leases
FinancingCashFlowsFromFinanceLeases
-4144 usd
GRST Financing Cash Flows From Finance Leases
FinancingCashFlowsFromFinanceLeases
-3883 usd
GRST Financing Cash Flows From Finance Leases Net
FinancingCashFlowsFromFinanceLeasesNet
-378915 usd
GRST Financing Cash Flows From Finance Leases Net
FinancingCashFlowsFromFinanceLeasesNet
-178558 usd
GRST Weighted Average Lease Term Finance Leases
WeightedAverageLeaseTermFinanceLeases
2 years and 5 months
GRST Weighted Average Lease Term Finance Leases
WeightedAverageLeaseTermFinanceLeases
3 years and 4 months
GRST Weighted Average Remaining Lease Term Operating Leases
WeightedAverageRemainingLeaseTermOperatingLeases
18 years
GRST Weighted Average Remaining Lease Term Operating Leases
WeightedAverageRemainingLeaseTermOperatingLeases
3 years and 7 months
CY2024Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0658 pure
CY2023Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0661 pure
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0760 pure
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0464 pure
CY2024Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
4915 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
9829 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
6195 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
1707 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
22646 usd
CY2024Q2 GRST Imputed Interest
ImputedInterest
-1915 usd
CY2024Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
20731 usd
CY2024Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
8714 usd
CY2024Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
12017 usd
CY2024Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
20731 usd
CY2024Q2 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
511915 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1045192 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1074288 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
961526 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
841379 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
15358663 usd
CY2024Q2 GRST Total Undiscounted Minimum Future Lease Payments
TotalUndiscountedMinimumFutureLeasePayments
19792963 usd
CY2024Q2 GRST Imputed Interest1
ImputedInterest1
-9526750 usd
CY2024Q2 GRST Lessee Operating Lease Liability Payments Due One
LesseeOperatingLeaseLiabilityPaymentsDueOne
10266213 usd
CY2024Q2 GRST Operating Leases Liability Current
OperatingLeasesLiabilityCurrent
271457 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9990756 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
10266213 usd
CY2024Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
2969776 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
929842 usd
CY2024Q2 us-gaap Debt Current
DebtCurrent
3899618 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
4419927 usd
CY2024Q2 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
2169570 usd
CY2023Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
4419927 usd
CY2024Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1730048 usd
CY2024Q2 us-gaap Debt Current
DebtCurrent
3899618 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
4419927 usd
GRST Debt Instrument Of Principal Amount
DebtInstrumentOfPrincipalAmount
2375053 usd
us-gaap Line Of Credit Facility Increase Accrued Interest
LineOfCreditFacilityIncreaseAccruedInterest
92601 usd
GRST Debt Instrument Unamortized Discounts
DebtInstrumentUnamortizedDiscounts
-88209 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
2379445 usd
CY2023 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
680672 usd
CY2024Q2 GRST Total Related Party Payables
TotalRelatedPartyPayables
2638078 usd
CY2023Q4 GRST Total Related Party Payables
TotalRelatedPartyPayables
2572292 usd
us-gaap Stock Option Exercise Price Decrease
StockOptionExercisePriceDecrease
0.001
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
602852506 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.001306
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
745810761 shares
CY2023 GRST Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice
0.001
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.001
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
326286847 shares
CY2023 GRST Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodExercisePrice
0.000675
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.000675
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1022376420 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.0012840
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1022376420 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.0012840
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
0 usd
CY2024Q2 GRST Shares Issuable Upon Exercise Of Warrants
SharesIssuableUponExerciseOfWarrants
1022376420 shares
GRST Shares Issuable Upon Exercise Of Warrants
SharesIssuableUponExerciseOfWarrants
1022376420 shares
CY2023Q2 GRST Shares Issuable Upon Exercise Of Warrants
SharesIssuableUponExerciseOfWarrants
692852506 shares
GRST Shares Issuable Upon Exercise Of Warrants
SharesIssuableUponExerciseOfWarrants
692852506 shares
CY2024Q2 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
174044742 shares
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
174044742 shares
CY2023Q2 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
582290570 shares
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
582290570 shares
CY2024Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1196421162 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1196421162 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1275143076 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1275143076 shares

Files In Submission

Name View Source Status
0001903596-24-000535-index-headers.html Edgar Link pending
0001903596-24-000535-index.html Edgar Link pending
0001903596-24-000535.txt Edgar Link pending
0001903596-24-000535-xbrl.zip Edgar Link pending
ex31_1.htm Edgar Link pending
ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
grst-20240630.xsd Edgar Link pending
grst_10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
grst-20240630_cal.xml Edgar Link unprocessable
grst-20240630_def.xml Edgar Link unprocessable
grst_10q_htm.xml Edgar Link completed
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
grst-20240630_lab.xml Edgar Link unprocessable
grst-20240630_pre.xml Edgar Link unprocessable